Pathway Capital Management, LP Vir Biotechnology, Inc. Transaction History

Pathway Capital Management, LP

  • $63.3 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$34.9 - $54.54 $16.5 Million - $25.8 Million
-472,552 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$38.75 - $51.0 $16.5 Million - $21.7 Million
425,297 Added 900.0%
472,552 $22.3 Million
Q1 2021

May 13, 2021
BUY
$26.34 - $83.07 $1.24 Million - $3.93 Million
47,255 New
47,255 $2.42 Million

Others Institutions Holding VIR

# of Institutions
233
Shares Held
87.6M
Call Options Held
231K
Put Options Held
132K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $974M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Pathway Capital Management, LP Portfolio

Follow Pathway Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email